Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.6118/jmm.2016.22.1.9 http://scihub22266oqcxt.onion/10.6118/jmm.2016.22.1.9 C4854663!4854663!27152308     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27152308&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Menopausal+Med 2016 ; 22 (1): 9-13 Nephropedia Template TP {{tp|p=27152308|t=2016. Flibanserin for Treating Hypoactive Sexual Desire Disorder |pdf=|usr=}}{{27152308}} gab.com Text Flibanserin for Treating Hypoactive Sexual Desire Disorder JO: J Menopausal Med http://www.kidney.de/pget.php?&tw=1&pmid=27152308 #FOAvip There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorder (HSDD) of premenopausal women in 2015, and is expected to be released in South Korea soon. Authors wrote this article to acknowledge flibanserin to sexologists for females or physicians for menopausal medicine, so that this agent can be safely used for females who have HSDD. Twit Text FOAVip Flibanserin for Treating Hypoactive Sexual Desire Disorder ????J Menopausal Med http://www.kidney.de/pget.php?&tw=1&pmid=27152308 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27152308 #FOAvip English Wikipedia <ref>{{Cite pmid|27152308}}</ref> Flibanserin for Treating Hypoactive Sexual Desire Disorder #MMPMID27152308 Sang JH; Kim TH; Kim SA J Menopausal Med 2016[Apr]; 22 (1): 9-13 PMID27152308show ga There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.[1] On the other hand, flibanserin is thought to act on brain. Flibanserin has been approved by U. S. Food and Drug Administration (FDA) for treatment of hypoactive sexual desire disorder (HSDD) of premenopausal women in 2015, and is expected to be released in South Korea soon. Authors wrote this article to acknowledge flibanserin to sexologists for females or physicians for menopausal medicine, so that this agent can be safely used for females who have HSDD. äFlibanserin for Treating Hypoactive Sexual Desire Disorder (epmc).pdf DeepDyve Pubget Overpricing